Loading chat...
NY A06848
Bill
Status
6/28/2010
Primary Sponsor
Robert Castelli
Click for details
AI Summary
-
Authorizes pharmacists in teaching hospitals and diagnostic/treatment centers to perform collaborative drug therapy management (CDTM) with physicians under written agreements or protocols
-
Permits pharmacists to adjust drug regimens, order clinical laboratory tests, and perform patient monitoring functions (vital signs, medical history review) when specifically authorized in the protocol
-
Requires participating pharmacists to hold a Master of Science or Doctor of Pharmacy degree with minimum 2 years experience (1 year clinical), or a Bachelor of Science in Pharmacy with minimum 3 years experience within the last 7 years (1 year clinical)
-
Mandates written patient consent before CDTM can be provided and requires disclosure to all treating physicians; participation is voluntary for patients, physicians, pharmacists, and facilities
-
Establishes a 3-year demonstration program with Department of Education reporting required 4 months before expiration on CDTM's impact on patient care quality, medication errors, and healthcare costs
Legislative Description
Permits pharmacists that practice in licensed health care facilities to engage in collaborative management of drug therapy to reduce potential medication errors and adverse reactions pursuant to voluntary agreements or protocols with physicians and patients.
Last Action
3RD READING CAL.68
6/29/2010